title: [Aplasia cutis after exposure to carbimazole in utero].
abstract: The authors report a case of a skin defect in the scalp of a child whose mother took carbimazole during her pregnancy. Including our case there are now 15 congenital scalp defects reported: however, these rare cases do not show that carbimazole should not be used during pregnancy.
authors.affiliation: Centre Régional de Pharmacovigilance, CHU Bretonneau, Tours.
authors.forename: J P
authors.initials: JP
authors.lastname: Dutertre
authors.forename: A P
authors.initials: AP
authors.lastname: Jonville
authors.forename: C
authors.initials: C
authors.lastname: Moraine
authors.forename: E
authors.initials: E
authors.lastname: Autret
mesh_terms: D000014:Abnormalities, Drug-Induced / Q000209:etiology* / Q000473:pathology; D002231:Carbimazole / Q000009:adverse effects*; D005260:Female; D006111:Graves Disease / Q000188:drug therapy*; D006801:Humans; D007231:Infant, Newborn; D008297:Male; D011247:Pregnancy; D011248:Pregnancy Complications / Q000188:drug therapy*; D012535:Scalp / Q000002:abnormalities*
chemical_list: D002231:Carbimazole
vernacular_title: Aplasia cutis après exposition in utero au carbimazole.